Tracie Bryson, MD
Dermatology · Advance, NCNPI 1982698288
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $832 of the $927 with a category attached, or 89.7%. It is spread thinly across 19 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $292 and has fallen 65.8% since, to $100 in 2025. That places this record below the midpoint for dermatology clinicians in NC, where the typical reported total is $2,057.
Across 35 payments — averaging $26.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$126
- AbbVie$108
- UCB, Inc.$99
- Dermira, Inc.$88
- Johnson & Johnson$80
- Pfizer$57
- plus $370 from 13 others
What the payments were for
- Food & beverage$83290%
- Education$9510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 3 | $126 |
| AbbVie | 6 | $108 |
| UCB, Inc. | 3 | $99 |
| Dermira, Inc. | 1 | $88 |
| Johnson & Johnson | 1 | $80 |
| Pfizer | 3 | $57 |
| Novartis | 2 | $54 |
| Incyte Corporation | 2 | $49 |
| LEO Pharma Inc. | 2 | $40 |
| Sun Pharmaceutical Industries Inc. | 2 | $39 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Biofrontera Inc. | 1 | $20 |
| GSK | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Botanix SB Inc | 1 | $17 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $17 |
| Almirall LLC | 1 | $15 |
How this compares
$927 in reported general payments places this provider in the 30th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 16 | $82,875 |
| Dupixent PenDupilumab | 13 | $50,583 |
| Fluorouracil | 126 | $10,246 |
| Metronidazole | 58 | $2,480 |
| Tretinoin | 34 | $1,907 |
| Clobetasol Propionate | 60 | $1,871 |
| Fluocinonide | 27 | $1,022 |
| Triamcinolone Acetonide | 112 | $932 |
| Ketoconazole | 56 | $874 |
| Diclofenac Sodium | 11 | $721 |
| Clindamycin Phos-Benzoyl PeroxClindamycin Phos/Benzoyl Perox | 13 | $652 |
| ValacyclovirValacyclovir Hcl | 43 | $507 |
| Imiquimod | 20 | $421 |
| Ciclopirox | 11 | $399 |
| Fluconazole | 22 | $299 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Advance
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- William HooverConcord$594K
- Patrick McElgunnCharlotte$565K
- George MagelHickory$554K
- Muneeb ShahClinton$451K
- John SoderbergCary$398K
- Rosalyn GeorgeWilmington$346K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.